Montreal, August 5, 2015 – ZoomMed Inc. (TSX-V: ZMD) (the “Corporation” or “ZoomMed”) – The Corporation announces the resignation of Mr. André Marmet as director of the Corporation, effective immediately. Mr. André Marmet was serving on the Board of Directors since the incorporation of the Corporation in 2005. The Corporation and the Board of Directors thank Mr. André Marmet for his his contribution during the past ten years, both by his leadership and his valuable advice. Mr. André Marmet will continue his functions as Vice-President Corporate Business.
ZoomMed builds and operates “ZoomMed’s communication network”, a clinical information exchange platform between physicians and the various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical corporations and private insurers. The cornerstone of this network is ZoomMed’s “ZRx Prescriber”, a technological innovative Web application that greatly simplifies the writing of a prescription for the physician. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR).
For further information on ZoomMed, contact Mr. Yves Marmet, President and Chief Executive Officer (450) 678-5457, Ext 228, firstname.lastname@example.org or visit our Web Site; www.zoommed.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements made in this news release that are not historical facts are “forward-looking statements” and readers are cautioned that any such statements are not guarantees of future performance, and that actual developments or results, may vary materially from those in these “forward-looking” statements.